Solara Active Pharma Sciences Operational Benchmarking
₹647.70-1.10%close, 9 Oct 2026
- Market cap
- ₹3,120 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹466.34 – ₹874.40
Solara Active Pharma Sciences compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Solara Active Pharma Sciences sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Solara Active Pharma Sciences Limited | ₹647.70 | 22.5 | 3,120 | 1.2% | 780 | 14.5% |
| Median (1 Cos) | ₹647.70 | 22.5 | 3,120 | 1.2% | 780 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Sun Pharma Advanced Research Company Limited operational benchmarking
- SMS Pharmaceuticals Limited operational benchmarking
- Strides Pharma Science Limited operational benchmarking
- Shilpa Medicare Limited operational benchmarking
- Sun Pharmaceutical Industries Limited operational benchmarking
- Senores Pharmaceuticals Limited operational benchmarking
Trade Solara Active Pharma Sciences With ATS
Track SOLARA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.